Calendar VALBIOTIS

Equities

Market Closed - Euronext Paris Other stock markets 16:35:26 26/04/2024 BST			5-day change	1st Jan Change
3.9 ^EUR	-1.64%		+0.91%	-22.00%

04-26	Valbiotis SA Reports Earnings Results for the Full Year Ended December 31, 2023	CI
04-03	Valbiotis: launch of Valbiotis PRO Cholesterol in May	CF

90d57dad2a8.qqfmRdua-rvwljMRHTajpxq5JrBVWwEFY4zlPmutu7A._9ecEOrKkI-2431hLFTl4UjAQt0kbHhrWsrUVQzq49OH4qkdvOmNibeiAw~0e9d40350249330014daa8459483ca9f

28/04/2024	Q4 2023 Earnings Release After hours
24/06/2024	Annual General Meeting
28/10/2024	Q2 2024 Earnings Release
11/03/2025	Q4 2024 Earnings Release (Projected)
24/09/2025	Q2 2025 Earnings Release (Projected)
17/03/2026	Q4 2025 Earnings Release (Projected)
23/09/2026	Q2 2026 Earnings Release (Projected)

27/09/2023	Q2 2023 Earnings Release
02/05/2023 08:30	Annual General Meeting
15/03/2023 16:40	Q4 2022 Earnings Release
03/11/2022	American learned society for liver diseases Conference
29/09/2022	Interim 2022 Earnings Release
05/05/2022 16:00	Shareholders Meeting
15/03/2022 16:40	FY 2021 Earnings Release
30/09/2021 06:35	Interim 2021 Earnings Release
27/05/2021 16:00	Shareholders Meeting
10/04/2021	ESH-ISH Meeting - TOTUM-854
17/03/2021 16:40	FY 2020 Earnings Release
10/01/2021	J.P. Morgan Healthcare Conference
29/09/2020	Interim 2020 Earnings Release
21/04/2020 06:35	FY 2019 Earnings Release
15/09/2019	European Association for the Study of Diabetes Meeting
23/06/2019	First HealthTech Investor Day
06/06/2019	American Diabetes Association Meeting
03/04/2019	FY 2018 Earnings Release (Projected)
06/01/2019	J.P. Morgan Healthcare Conference
03/12/2018	Geneva European Midcap Event

Fiscal Period	December	2018	2019	2020	2021	2022	2023
Net sales Million EUR	Released Forecast Spread	1,51 0,00 -	1,91 1,90 0.68%	5,10 6,57 -22.35%	2,69 3,75 -28.19%	2,81 2,67 5.52%	6,81 6,63 2.65%
EBITDA Million EUR	Released Forecast Spread	0,00 0,00 -	0,00 0,00 -	-2,37 -2,30 -3.04%	-7,53 -5,10 -47.73%	-11,2 -10,6 -5.42%	0,00 -8,60 -
EBIT Million EUR	Released Forecast Spread	-4,88 -6,70 27.22%	-5,16 -5,70 9.53%	-3,41 -2,58 -32.05%	-8,48 -5,65 -50%	-12,0 -12,1 0.34%	-7,18 -10,4 30.96%
Earnings before Tax (EBT) Million EUR	Released Forecast Spread	0,00 0,00 -	0,00 0,00 -	-3,83 -3,68 -4.05%	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -
Net income Million EUR	Released Forecast Spread	-4,97 -6,70 25.87%	-5,50 -5,70 3.44%	-3,83 -2,40 -59.54%	-8,68 -5,45 -59.28%	-12,3 -12,2 -1.19%	-7,37 -10,6 30.16%
EPS EUR	Released Forecast Spread	0,00 0,00 -	-1,18 -0,78 -50.5%	-0,52 -0,34 -53.07%	-0,94 -0,77 -22.81%	-1,21 -1,20 -1.26%	0,00 -0,94 -
Announcement Date		08/03/19	21/04/20	16/03/21	15/03/22	15/03/23	26/04/24

28/04/2024	HITGEN INC.: Q1 2024 Earnings Release (Projected)
28/04/2024	CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release (Projected)
29/04/2024	DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
29/04/2024	ARVINAS, INC.: Q1 2024 Earnings Release (Projected)
29/04/2024	MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q1 2024 Earnings Release
29/04/2024	WUXI APPTEC CO., LTD.: Q1 2024 Earnings Release
30/04/2024 21:05	EXELIXIS, INC.: Q1 2024 Earnings Release
30/04/2024	SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release
30/04/2024	MACROGENICS, INC.: Q1 2024 Earnings Release (Projected)
30/04/2024	REGENXBIO INC.: Q1 2024 Earnings Release (Projected)

25/04/2024	INVENTISBIO CO., LIMITED: Q4 2023 Earnings Release
25/04/2024	SHANGHAI MEDICILON INC.: Q1 2024 Earnings Release (Projected)
25/04/2024	SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release (Projected)
25/04/2024	DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
25/04/2024	SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release
25/04/2024	REMEGEN CO., LTD.: Q1 2024 Earnings Release
25/04/2024 21:05	PTC THERAPEUTICS, INC.: Q1 2024 Earnings Release
25/04/2024 11:30	SAGE THERAPEUTICS, INC.: Q1 2024 Earnings Release
24/04/2024	JIANGSU YAHONG MEDITECH CO., LTD.: Q1 2024 Earnings Release (Projected)
24/04/2024	BIO-THERA SOLUTIONS, LTD.: Q1 2024 Earnings Release (Projected)